Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Irene Attucci"'
Autor:
Irene Attucci, Sofia Pilerci, Maria Messeri, Ludovica Pengue, Giulia Tomasino, Leonardo Caroti, Alessandro M. Vannucchi, Elisabetta Antonioli
Publikováno v:
Cancer Reports, Vol 7, Iss 10, Pp n/a-n/a (2024)
ABSTRACTBackgroundThrombotic microangiopathy (TMA) is a pathological syndrome characterized by a combination of three key features: microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and organ damage, primarily affecting the kidneys. There a
Externí odkaz:
https://doaj.org/article/e2f4fd4560f144f5a0448599655f8902
Autor:
Elisabetta Antonioli, Sofia Pilerci, Irene Attucci, Gabriele Buda, Alessandro Gozzetti, Veronica Candi, Federico Simonetti, Maria Livia Del Giudice, Sara Ciofini, Michela Staderini, Sara Grammatico, Alessandra Buzzichelli, Maria Messeri, Monica Bocchia, Sara Galimberti, Alessandro M. Vannucchi
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionCarfilzomib, a potent, irreversible, selective proteasome inhibitor has demonstrated consistent results in relapsed/refractory multiple myeloma (RRMM) combined with lenalidomide and dexamethasone (KRd). No prospective studies are yet avai
Externí odkaz:
https://doaj.org/article/0187b91cd2a6449081286e4dd3695ef6
Autor:
Maria Livia Del Giudice, Alessandro Gozzetti, Elisabetta Antonioli, Enrico Orciuolo, Francesco Ghio, Sara Ciofini, Veronica Candi, Giulia Fontanelli, Irene Attucci, Giuseppe Formica, Monica Bocchia, Sara Galimberti, Mario Petrini, Gabriele Buda
Publikováno v:
Medicina, Vol 57, Iss 9, p 900 (2021)
Background and Objectives: The treatment of Myeloma after the second relapse is still challenging. The aim of the study was to investigate the outcomes of the POM-DEX regimen in real clinical practice. Materials and Methods: We retrospectively and pr
Externí odkaz:
https://doaj.org/article/3fe837b718724a06912df20ad09277e3
Autor:
Maria Livia Del Giudice, Alessandro Gozzetti, Elisabetta Antonioli, Irene Attucci, Ludovica Pengue, Raffaella Cassano Cassano, Francesco Ghio, Enrico Orciuolo, Martina Simoncelli, Monica Bocchia, Sara Galimberti, Gabriele Buda
Publikováno v:
European Journal of Haematology. 109:373-380
We investigate safety and efficacy in common clinical practice of the combination of carfilzomib and dexamethasone (Kd56) approved for the ENDEAVOR trial for the treatment of relapsed or refractory multiple myeloma.We retro-prospective analyzed 75 pa
Autor:
Sara Bringhen, Mattia D'Agostino, Nicola Giuliani, Irene Attucci, Renato Zambello, Sonia Ronconi, Iolanda Donatella Vincelli, Alessandro Allegra, Giovanna Leonardi, Giuseppe Rossi, Francesco Cattel, Andrea Capra, Piero Galieni, Alessandra Lombardo, Francesca Bonello, Patrizia Tosi, Maide Maria Cavalli, Elisa Sciorsi, Donato Mannina, Roberto Ria, Francesca Patriarca, Michele Cavo, Silvia Mangiacavalli, Giulia Benevolo, Andrea Evangelista, Mario Boccadoro, Benedetto Bruno, Alessandra Larocca
Publikováno v:
Blood. 140:1814-1816
Autor:
Marianna Palazzo, Gaia Ciolli, Sofia Pilerci, Irene Attucci, Ludovica Pengue, Alessandro Maria Vannucchi, Elisabetta Antonioli
Publikováno v:
Frontiers in Hematology. 1
Multiple myeloma patients have an increased risk of infections due to both the inherent nature of the disease and ongoing treatment. We describe the case of a patient who was treated with daratumumab-lenalidomide-dexamethasone regimen for two years a
Daratumumab in AL Amyloidosis: A Real-Life Experience of the “RTM” (Regional Tuscan Myeloma Network)
Autor:
Gozzetti, Vincenzo Sammartano, Elisabetta Antonioli, Gabriele Buda, Sara Ciofini, Veronica Candi, Ludovica Pengue, Maria Livia Del Giudice, Irene Attucci, Francesca Bacchiarri, Ubaldo Occhini, Maria Teresa Pirrotta, Federico Perfetto, Monica Bocchia, Alessandro
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 3; Pages: 484
Systemic amyloidosis arises from monoclonal CD38+ plasma cells that produce misfolded immunoglobulin light chains, which form amyloid fibrils that are deposited into different tissues, leading to organ damage. Daratumumab is a human IgG/k monoclonal
Daratumumab in AL Amyloidosis: A Real-Life Experience of the 'RTM' (Regional Tuscan Myeloma Network)
Autor:
Vincenzo Sammartano, Elisabetta Antonioli, Gabriele Buda, Sara Ciofini, Veronica Candi, Ludovica Pengue, Maria Livia Del Giudice, Irene Attucci, Francesca Bacchiarri, Ubaldo Occhini, Maria Teresa Pirrotta, Federico Perfetto, Monica Bocchia, Alessandro Gozzetti
Publikováno v:
Journal of Personalized Medicine. 12:484
Systemic amyloidosis arises from monoclonal CD38+ plasma cells that produce misfolded immunoglobulin light chains, which form amyloid fibrils that are deposited into different tissues, leading to organ damage. Daratumumab is a human IgG/k monoclonal
Autor:
Francesco Cappelli, Federico Perfetto, Michela Staderini, Marco Allinovi, Irene Attucci, Sofia Pilerci, Alberto Bosi, Chiara Nozzoli, Elisabetta Antonioli, Maria Messeri, Alessandra Buzzichelli
Publikováno v:
Leukemialymphoma. 61(13)
In recent years, the clinical outcome of multiple myeloma (MM) patients has improved due to the introduction of several new agents and of immunotherapy. The combination of novel drugs has allowed i...